Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs dual vs single antiplatelet therapy in acute cerebral infarction and TIA
ChiCTR-OPN-16007931Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in brain infarction and transient ischaemic attack (TIA) comparing Unfractionated heparin plus aspirin, Dual antiplatelet therapy (aspirin plus clopidogrel) and Single antiplatelet therapy (aspirin) (3 arms). Primary endpoints: NIHSS score, Modified Rankin Scale score and 7 more. Started Nov 2016; status: recruiting.
02
Drugs
heparinaspirinclopidogrel
03
Conditions
brain infarctiontransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ChiCTR-OPN-16007931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16007931.